Results 81 to 90 of about 2,291,030 (290)

Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are a relatively new class of drugs that were initially approved by the US Food and Drug Administration to improve glycemic control in patients with type 2 diabetes mellitus and, subsequently, weight reduction in patients with obesity.
Audrey Y. Chang, Farrah J. Mateen
wiley   +1 more source

1995 annual epidemiologic surveillance report for Idaho National Engineering and Environmental Laboratory

open access: yes, 1995
The US Department of Energy's (DOE) conduct of epidemiologic surveillance provides an early warning system for health problems among workers. This program monitors illnesses and health conditions that result in an absence of five or more consecutive ...

core   +1 more source

Dysregulated Cholesterol Metabolism, Chronic Inflammation, and Disability in Severe Progressive Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Dysregulated lipid metabolism, which can affect remyelination and neural repair, has not been extensively investigated in progressive multiple sclerosis (PMS). The goal was to examine whether dysregulated cholesterol metabolism was associated with disability in PMS. Methods The study sample comprised 53 Severe PMS patients (Expanded
Taylor R. Wicks   +8 more
wiley   +1 more source

Convergences and divergences in mortality

open access: yesDemographic Research, 2004
Abdel Omran's 1971 theory of "Epidemiologic Transition" was the first attempt to account for the extraordinary advances in health care made in industrialized countries since the 18th century.
doaj  

Integration of communicable and non-communicable diseases within the health system of India: A window of opportunity?

open access: yesFrontiers in Public Health, 2023
Sudip Bhattacharya   +4 more
doaj   +1 more source

[Molecular epidemiology in the epidemiological transition].

open access: yesGaceta medica de Mexico, 1998
The epidemiological transition describes the changes in the health profile of populations where infectious diseases are substituted by chronic or non-communicable diseases. Even in industrialized countries, infectious diseases emerge as important public health problems and with a very important association with several type of neoplasm.
openaire   +1 more source

Cerebrospinal Fluid GAD65‐Antibody Levels Accurately Identify Relevant Neurological Diseases

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Retrospective cohort study to investigate which factors most reliably distinguish incidental GAD65‐antibodies (iGAD65) from true GAD65‐antibody neurological disease (tGAD65). 167 adults with positive serum and CSF GAD65‐antibodies (> 0.02 nmol/L by radioimmunoassay) were classified as tGAD65 or iGAD65, with diagnostic performance of ...
Max Charles Herman   +9 more
wiley   +1 more source

Epidemiologic Transition in Iran with Emphasis on the Third Stage of Transition

open access: yesJournal of Community Health Research, 2017
Introduction: During the last half century, all indices of mortality imply the prompt and continuous decrease of nationwide mortality. Alongside reduction of mortality, there happened a comprehensive form of transition of mortality causes, from ...
mohamad sasanipour, Sajjad Asadi
doaj  

Epidemiologic data.

open access: yes, 2014
Epidemiologic data.
Christian Maihöfner (226224)   +4 more
core   +1 more source

Modeling the hepatitis A epidemiological transition in Thailand

open access: yesVaccine, 2016
In most low- and middle-income countries, hepatitis A virus (HAV) is shifting or expected to shift from high endemicity to intermediate or low endemicity. A decreased risk of HAV infection will cause an increase in the average age at infection and will therefore increase the proportion of infections that results in severe disease.
Van Effelterre, Thierry   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy